Northern Trust’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.65M | Sell |
273,123
-16,888
| -6% | -$225K | ﹤0.01% | 2649 |
|
|
2025
Q1 | $2.96M | Sell |
290,011
-6,456
| -2% | -$65.8K | ﹤0.01% | 2704 |
|
|
2024
Q4 | $4.69M | Buy |
296,467
+30,111
| +11% | +$477K | ﹤0.01% | 2542 |
|
|
2024
Q3 | $15.5M | Buy |
266,356
+29,868
| +13% | +$1.73M | ﹤0.01% | 1796 |
|
|
2024
Q2 | $10.8M | Buy |
236,488
+850
| +0.4% | +$38.8K | ﹤0.01% | 1948 |
|
|
2024
Q1 | $15.6M | Buy |
235,638
+18,792
| +9% | +$1.24M | ﹤0.01% | 1762 |
|
|
2023
Q4 | $8.62M | Buy |
216,846
+3,947
| +2% | +$157K | ﹤0.01% | 2160 |
|
|
2023
Q3 | $6.79M | Buy |
212,899
+9,216
| +5% | +$294K | ﹤0.01% | 2255 |
|
|
2023
Q2 | $8.18M | Buy |
203,683
+26,413
| +15% | +$1.06M | ﹤0.01% | 2207 |
|
|
2023
Q1 | $7.57M | Buy |
177,270
+2,506
| +1% | +$107K | ﹤0.01% | 2207 |
|
|
2022
Q4 | $8.39M | Buy |
174,764
+11,817
| +7% | +$567K | ﹤0.01% | 2127 |
|
|
2022
Q3 | $6.13M | Buy |
162,947
+12,446
| +8% | +$468K | ﹤0.01% | 2333 |
|
|
2022
Q2 | $4.16M | Buy |
150,501
+1,984
| +1% | +$54.8K | ﹤0.01% | 2623 |
|
|
2022
Q1 | $8.08M | Sell |
148,517
-5,655
| -4% | -$308K | ﹤0.01% | 2281 |
|
|
2021
Q4 | $9.02M | Buy |
154,172
+4,552
| +3% | +$266K | ﹤0.01% | 2306 |
|
|
2021
Q3 | $5.92M | Sell |
149,620
-5,318
| -3% | -$210K | ﹤0.01% | 2625 |
|
|
2021
Q2 | $6.58M | Buy |
154,938
+27,068
| +21% | +$1.15M | ﹤0.01% | 2663 |
|
|
2021
Q1 | $7.87M | Sell |
127,870
-7,371
| -5% | -$454K | ﹤0.01% | 2458 |
|
|
2020
Q4 | $9.54M | Buy |
135,241
+51,895
| +62% | +$3.66M | ﹤0.01% | 2277 |
|
|
2020
Q3 | $3.22M | Sell |
83,346
-4,309
| -5% | -$166K | ﹤0.01% | 2799 |
|
|
2020
Q2 | $3.29M | Buy |
+87,655
| New | +$3.29M | ﹤0.01% | 2767 |
|